Global Natamycin

Natamycin Comprehensive Study by Application (Dairy Products (Cheese, Sour Cream, Yoghurt), Dried Meats, Juices, Pharmaceuticals, Others), Packaging (Plastic Bottle, Glass Containers, Stainless Steel Containers), Sources (Plants, Animals, Microorganisms) Players and Region - Global Market Outlook to 2030

Natamycin Market by XX Submarkets | Forecast Years 2024-2030 | CAGR: 3.2%  

Access Sample Report Make An Enquiry Before Purchase
  • Summary
  • Market Segments
  • Table of Content
  • List of Table & Figures
  • Players Profiled
About Natamycin
Natamycin is a fungicide which avoids yeasts and moulds from appearing in foods. It is very effective when used in lesser amounts. It is used in small extents as compare to potassium sorbate and unlike other sorbates it prevents yeasts and fungi from migrating into the product, eliminating the cost of reapplication. The action of natamycin does not destroy other bacteria, which means that it does not alter the food natural maturing process. Natamycin is different from other antimicrobial agents as it does not affect the appearance, taste or colour of the products.

AttributesDetails
Study Period2018-2030
Base Year2023
UnitValue (USD Million)
CAGR3.2%


Global Natamycin is a fragmented market due to the presence of various players. The players are focusing on investing more in Launching Products. These will enhance their market presence. The companies are also planning strategic activities like partnerships, mergers, and acquisitions which will help them to sustain in the market and maintain their competitive edge. Analyst at AMA Research estimates that Chinese Vendors will contribute the maximum growth to Global Natamycin market throughout the forecasted period. Established and emerging Vendors should take a closer view at their existing organizations and reinvent traditional business and operating models to adapt to the future.

Danisco (Denmark), Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China), Lanzhou Weiri (China), Meihua Holdings Group Co., Ltd (China), Chihon Biotechnology (China), VGP Pharmachem (Spain), Beijing Oriental Rada Biotech Co., Ltd. (China), Toku-E Company (United States), D & F Control Systems Inc. (United States) and Avanscure Lifesciences Pvt. Ltd. (India) are some of the key players that are part of study coverage.

Segmentation Overview
AMA Research has segmented the market of Global Natamycin market by , Application (Dairy Products (Cheese, Sour Cream, Yoghurt), Dried Meats, Juices, Pharmaceuticals and Others) and Region.



On the basis of geography, the market of Natamycin has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). If we see Market by Packaging, the sub-segment i.e. Plastic Bottle will boost the Natamycin market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth. If we see Market by Sources, the sub-segment i.e. Plants will boost the Natamycin market. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.

Influencing Trend:
Growing Use in Antifungal Pharmaceutical Products

Market Growth Drivers:
Rising Demand from Food Industry to extend the Shelf Life of Food and Increasing Consumption of Dairy Product

Challenges:
Absence of Reliable Techniques for Developing a Robust

Restraints:
Use of Artificial Chemical Preservatives as a Substitutes

Opportunities:
New Product Development Using Stabilizing Additives to Improve Stability

In October 2023, Harrow Completes Transfer of NDAs and Launches FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, and ZERVIATE in the U.S, Product orders for FLAREX, NATACYN, TOBRADEX ST, VERKAZIA, and ZERVIATE can be made directly through Harrow’s dedicated customer service ordering partner, Cardinal’s Cordlogistics, which includes a wholesaler distribution system encompassing McKesson and Amerisource Bergen.
(EU) 438/2013 of the European Commission, 13 May 2013, modifies and corrects annex II of Regulation (EC) 1333/2008 of the European Parliament and Council with regard to the use of certain food additives. In this Regulation, Natamycin (E 235) is authorised, amongst other additives, in the surface treatment of cold slice and for different food products.

Key Target Audience
Manufacturers of Natamycin, Suppliers of Natamycin, Wholesalers, Distributors, and Retailers of Natamycin, Healthcare Industry, Food & Beverages Industry, Research Organization and Governmental Bodies

About Approach
To evaluate and validate the market size various sources including primary and secondary analysis is utilized. AMA Research follows regulatory standards such as NAICS/SIC/ICB/TRCB, to have a better understanding of the market. The market study is conducted on basis of more than 200 companies dealing in the market regional as well as global areas with the purpose to understand the companies positioning regarding the market value, volume, and their market share for regional as well as global.

Further to bring relevance specific to any niche market we set and apply a number of criteria like Geographic Footprints, Regional Segments of Revenue, Operational Centres, etc. The next step is to finalize a team (In-House + Data Agencies) who then starts collecting C & D level executives and profiles, Industry experts, Opinion leaders, etc., and work towards appointment generation.

The primary research is performed by taking the interviews of executives of various companies dealing in the market as well as using the survey reports, research institute, and latest research reports. Meanwhile, the analyst team keeps preparing a set of questionnaires, and after getting the appointee list; the target audience is then tapped and segregated with various mediums and channels that are feasible for making connections that including email communication, telephonic, skype, LinkedIn Group & InMail, Community Forums, Community Forums, open Survey, SurveyMonkey, etc.

Report Objectives / Segmentation Covered

By Application
  • Dairy Products (Cheese, Sour Cream, Yoghurt)
  • Dried Meats
  • Juices
  • Pharmaceuticals
  • Others
By Packaging
  • Plastic Bottle
  • Glass Containers
  • Stainless Steel Containers

By Sources
  • Plants
  • Animals
  • Microorganisms

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rising Demand from Food Industry to extend the Shelf Life of Food
      • 3.2.2. Increasing Consumption of Dairy Product
    • 3.3. Market Challenges
      • 3.3.1. Absence of Reliable Techniques for Developing a Robust
    • 3.4. Market Trends
      • 3.4.1. Growing Use in Antifungal Pharmaceutical Products
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Natamycin, by Application, Packaging, Sources and Region (value, volume and price ) (2018-2023)
    • 5.1. Introduction
    • 5.2. Global Natamycin (Value)
      • 5.2.1. Global Natamycin by: Application (Value)
        • 5.2.1.1. Dairy Products (Cheese, Sour Cream, Yoghurt)
        • 5.2.1.2. Dried Meats
        • 5.2.1.3. Juices
        • 5.2.1.4. Pharmaceuticals
        • 5.2.1.5. Others
      • 5.2.2. Global Natamycin by: Packaging (Value)
        • 5.2.2.1. Plastic Bottle
        • 5.2.2.2. Glass Containers
        • 5.2.2.3. Stainless Steel Containers
      • 5.2.3. Global Natamycin by: Sources (Value)
        • 5.2.3.1. Plants
        • 5.2.3.2. Animals
        • 5.2.3.3. Microorganisms
      • 5.2.4. Global Natamycin Region
        • 5.2.4.1. South America
          • 5.2.4.1.1. Brazil
          • 5.2.4.1.2. Argentina
          • 5.2.4.1.3. Rest of South America
        • 5.2.4.2. Asia Pacific
          • 5.2.4.2.1. China
          • 5.2.4.2.2. Japan
          • 5.2.4.2.3. India
          • 5.2.4.2.4. South Korea
          • 5.2.4.2.5. Australia
          • 5.2.4.2.6. Rest of Asia-Pacific
        • 5.2.4.3. Europe
          • 5.2.4.3.1. Germany
          • 5.2.4.3.2. France
          • 5.2.4.3.3. Italy
          • 5.2.4.3.4. United Kingdom
          • 5.2.4.3.5. Netherlands
          • 5.2.4.3.6. Rest of Europe
        • 5.2.4.4. MEA
          • 5.2.4.4.1. Middle East
          • 5.2.4.4.2. Africa
        • 5.2.4.5. North America
          • 5.2.4.5.1. United States
          • 5.2.4.5.2. Canada
          • 5.2.4.5.3. Mexico
    • 5.3. Global Natamycin (Volume)
      • 5.3.1. Global Natamycin by: Application (Volume)
        • 5.3.1.1. Dairy Products (Cheese, Sour Cream, Yoghurt)
        • 5.3.1.2. Dried Meats
        • 5.3.1.3. Juices
        • 5.3.1.4. Pharmaceuticals
        • 5.3.1.5. Others
      • 5.3.2. Global Natamycin by: Packaging (Volume)
        • 5.3.2.1. Plastic Bottle
        • 5.3.2.2. Glass Containers
        • 5.3.2.3. Stainless Steel Containers
      • 5.3.3. Global Natamycin by: Sources (Volume)
        • 5.3.3.1. Plants
        • 5.3.3.2. Animals
        • 5.3.3.3. Microorganisms
      • 5.3.4. Global Natamycin Region
        • 5.3.4.1. South America
          • 5.3.4.1.1. Brazil
          • 5.3.4.1.2. Argentina
          • 5.3.4.1.3. Rest of South America
        • 5.3.4.2. Asia Pacific
          • 5.3.4.2.1. China
          • 5.3.4.2.2. Japan
          • 5.3.4.2.3. India
          • 5.3.4.2.4. South Korea
          • 5.3.4.2.5. Australia
          • 5.3.4.2.6. Rest of Asia-Pacific
        • 5.3.4.3. Europe
          • 5.3.4.3.1. Germany
          • 5.3.4.3.2. France
          • 5.3.4.3.3. Italy
          • 5.3.4.3.4. United Kingdom
          • 5.3.4.3.5. Netherlands
          • 5.3.4.3.6. Rest of Europe
        • 5.3.4.4. MEA
          • 5.3.4.4.1. Middle East
          • 5.3.4.4.2. Africa
        • 5.3.4.5. North America
          • 5.3.4.5.1. United States
          • 5.3.4.5.2. Canada
          • 5.3.4.5.3. Mexico
    • 5.4. Global Natamycin (Price)
  • 6. Natamycin: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2023)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Danisco (Denmark)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Lanzhou Weiri (China)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Meihua Holdings Group Co., Ltd (China)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Chihon Biotechnology (China)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. VGP Pharmachem (Spain)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Beijing Oriental Rada Biotech Co., Ltd. (China)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Toku-E Company (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. D & F Control Systems Inc. (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Avanscure Lifesciences Pvt. Ltd. (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Natamycin Sale, by Application, Packaging, Sources and Region (value, volume and price ) (2025-2030)
    • 7.1. Introduction
    • 7.2. Global Natamycin (Value)
      • 7.2.1. Global Natamycin by: Application (Value)
        • 7.2.1.1. Dairy Products (Cheese, Sour Cream, Yoghurt)
        • 7.2.1.2. Dried Meats
        • 7.2.1.3. Juices
        • 7.2.1.4. Pharmaceuticals
        • 7.2.1.5. Others
      • 7.2.2. Global Natamycin by: Packaging (Value)
        • 7.2.2.1. Plastic Bottle
        • 7.2.2.2. Glass Containers
        • 7.2.2.3. Stainless Steel Containers
      • 7.2.3. Global Natamycin by: Sources (Value)
        • 7.2.3.1. Plants
        • 7.2.3.2. Animals
        • 7.2.3.3. Microorganisms
      • 7.2.4. Global Natamycin Region
        • 7.2.4.1. South America
          • 7.2.4.1.1. Brazil
          • 7.2.4.1.2. Argentina
          • 7.2.4.1.3. Rest of South America
        • 7.2.4.2. Asia Pacific
          • 7.2.4.2.1. China
          • 7.2.4.2.2. Japan
          • 7.2.4.2.3. India
          • 7.2.4.2.4. South Korea
          • 7.2.4.2.5. Australia
          • 7.2.4.2.6. Rest of Asia-Pacific
        • 7.2.4.3. Europe
          • 7.2.4.3.1. Germany
          • 7.2.4.3.2. France
          • 7.2.4.3.3. Italy
          • 7.2.4.3.4. United Kingdom
          • 7.2.4.3.5. Netherlands
          • 7.2.4.3.6. Rest of Europe
        • 7.2.4.4. MEA
          • 7.2.4.4.1. Middle East
          • 7.2.4.4.2. Africa
        • 7.2.4.5. North America
          • 7.2.4.5.1. United States
          • 7.2.4.5.2. Canada
          • 7.2.4.5.3. Mexico
    • 7.3. Global Natamycin (Volume)
      • 7.3.1. Global Natamycin by: Application (Volume)
        • 7.3.1.1. Dairy Products (Cheese, Sour Cream, Yoghurt)
        • 7.3.1.2. Dried Meats
        • 7.3.1.3. Juices
        • 7.3.1.4. Pharmaceuticals
        • 7.3.1.5. Others
      • 7.3.2. Global Natamycin by: Packaging (Volume)
        • 7.3.2.1. Plastic Bottle
        • 7.3.2.2. Glass Containers
        • 7.3.2.3. Stainless Steel Containers
      • 7.3.3. Global Natamycin by: Sources (Volume)
        • 7.3.3.1. Plants
        • 7.3.3.2. Animals
        • 7.3.3.3. Microorganisms
      • 7.3.4. Global Natamycin Region
        • 7.3.4.1. South America
          • 7.3.4.1.1. Brazil
          • 7.3.4.1.2. Argentina
          • 7.3.4.1.3. Rest of South America
        • 7.3.4.2. Asia Pacific
          • 7.3.4.2.1. China
          • 7.3.4.2.2. Japan
          • 7.3.4.2.3. India
          • 7.3.4.2.4. South Korea
          • 7.3.4.2.5. Australia
          • 7.3.4.2.6. Rest of Asia-Pacific
        • 7.3.4.3. Europe
          • 7.3.4.3.1. Germany
          • 7.3.4.3.2. France
          • 7.3.4.3.3. Italy
          • 7.3.4.3.4. United Kingdom
          • 7.3.4.3.5. Netherlands
          • 7.3.4.3.6. Rest of Europe
        • 7.3.4.4. MEA
          • 7.3.4.4.1. Middle East
          • 7.3.4.4.2. Africa
        • 7.3.4.5. North America
          • 7.3.4.5.1. United States
          • 7.3.4.5.2. Canada
          • 7.3.4.5.3. Mexico
    • 7.4. Global Natamycin (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Natamycin: by Application(USD Million)
  • Table 2. Natamycin Dairy Products (Cheese, Sour Cream, Yoghurt) , by Region USD Million (2018-2023)
  • Table 3. Natamycin Dried Meats , by Region USD Million (2018-2023)
  • Table 4. Natamycin Juices , by Region USD Million (2018-2023)
  • Table 5. Natamycin Pharmaceuticals , by Region USD Million (2018-2023)
  • Table 6. Natamycin Others , by Region USD Million (2018-2023)
  • Table 7. Natamycin: by Packaging(USD Million)
  • Table 8. Natamycin Plastic Bottle , by Region USD Million (2018-2023)
  • Table 9. Natamycin Glass Containers , by Region USD Million (2018-2023)
  • Table 10. Natamycin Stainless Steel Containers , by Region USD Million (2018-2023)
  • Table 11. Natamycin: by Sources(USD Million)
  • Table 12. Natamycin Plants , by Region USD Million (2018-2023)
  • Table 13. Natamycin Animals , by Region USD Million (2018-2023)
  • Table 14. Natamycin Microorganisms , by Region USD Million (2018-2023)
  • Table 15. South America Natamycin, by Country USD Million (2018-2023)
  • Table 16. South America Natamycin, by Application USD Million (2018-2023)
  • Table 17. South America Natamycin, by Packaging USD Million (2018-2023)
  • Table 18. South America Natamycin, by Sources USD Million (2018-2023)
  • Table 19. Brazil Natamycin, by Application USD Million (2018-2023)
  • Table 20. Brazil Natamycin, by Packaging USD Million (2018-2023)
  • Table 21. Brazil Natamycin, by Sources USD Million (2018-2023)
  • Table 22. Argentina Natamycin, by Application USD Million (2018-2023)
  • Table 23. Argentina Natamycin, by Packaging USD Million (2018-2023)
  • Table 24. Argentina Natamycin, by Sources USD Million (2018-2023)
  • Table 25. Rest of South America Natamycin, by Application USD Million (2018-2023)
  • Table 26. Rest of South America Natamycin, by Packaging USD Million (2018-2023)
  • Table 27. Rest of South America Natamycin, by Sources USD Million (2018-2023)
  • Table 28. Asia Pacific Natamycin, by Country USD Million (2018-2023)
  • Table 29. Asia Pacific Natamycin, by Application USD Million (2018-2023)
  • Table 30. Asia Pacific Natamycin, by Packaging USD Million (2018-2023)
  • Table 31. Asia Pacific Natamycin, by Sources USD Million (2018-2023)
  • Table 32. China Natamycin, by Application USD Million (2018-2023)
  • Table 33. China Natamycin, by Packaging USD Million (2018-2023)
  • Table 34. China Natamycin, by Sources USD Million (2018-2023)
  • Table 35. Japan Natamycin, by Application USD Million (2018-2023)
  • Table 36. Japan Natamycin, by Packaging USD Million (2018-2023)
  • Table 37. Japan Natamycin, by Sources USD Million (2018-2023)
  • Table 38. India Natamycin, by Application USD Million (2018-2023)
  • Table 39. India Natamycin, by Packaging USD Million (2018-2023)
  • Table 40. India Natamycin, by Sources USD Million (2018-2023)
  • Table 41. South Korea Natamycin, by Application USD Million (2018-2023)
  • Table 42. South Korea Natamycin, by Packaging USD Million (2018-2023)
  • Table 43. South Korea Natamycin, by Sources USD Million (2018-2023)
  • Table 44. Australia Natamycin, by Application USD Million (2018-2023)
  • Table 45. Australia Natamycin, by Packaging USD Million (2018-2023)
  • Table 46. Australia Natamycin, by Sources USD Million (2018-2023)
  • Table 47. Rest of Asia-Pacific Natamycin, by Application USD Million (2018-2023)
  • Table 48. Rest of Asia-Pacific Natamycin, by Packaging USD Million (2018-2023)
  • Table 49. Rest of Asia-Pacific Natamycin, by Sources USD Million (2018-2023)
  • Table 50. Europe Natamycin, by Country USD Million (2018-2023)
  • Table 51. Europe Natamycin, by Application USD Million (2018-2023)
  • Table 52. Europe Natamycin, by Packaging USD Million (2018-2023)
  • Table 53. Europe Natamycin, by Sources USD Million (2018-2023)
  • Table 54. Germany Natamycin, by Application USD Million (2018-2023)
  • Table 55. Germany Natamycin, by Packaging USD Million (2018-2023)
  • Table 56. Germany Natamycin, by Sources USD Million (2018-2023)
  • Table 57. France Natamycin, by Application USD Million (2018-2023)
  • Table 58. France Natamycin, by Packaging USD Million (2018-2023)
  • Table 59. France Natamycin, by Sources USD Million (2018-2023)
  • Table 60. Italy Natamycin, by Application USD Million (2018-2023)
  • Table 61. Italy Natamycin, by Packaging USD Million (2018-2023)
  • Table 62. Italy Natamycin, by Sources USD Million (2018-2023)
  • Table 63. United Kingdom Natamycin, by Application USD Million (2018-2023)
  • Table 64. United Kingdom Natamycin, by Packaging USD Million (2018-2023)
  • Table 65. United Kingdom Natamycin, by Sources USD Million (2018-2023)
  • Table 66. Netherlands Natamycin, by Application USD Million (2018-2023)
  • Table 67. Netherlands Natamycin, by Packaging USD Million (2018-2023)
  • Table 68. Netherlands Natamycin, by Sources USD Million (2018-2023)
  • Table 69. Rest of Europe Natamycin, by Application USD Million (2018-2023)
  • Table 70. Rest of Europe Natamycin, by Packaging USD Million (2018-2023)
  • Table 71. Rest of Europe Natamycin, by Sources USD Million (2018-2023)
  • Table 72. MEA Natamycin, by Country USD Million (2018-2023)
  • Table 73. MEA Natamycin, by Application USD Million (2018-2023)
  • Table 74. MEA Natamycin, by Packaging USD Million (2018-2023)
  • Table 75. MEA Natamycin, by Sources USD Million (2018-2023)
  • Table 76. Middle East Natamycin, by Application USD Million (2018-2023)
  • Table 77. Middle East Natamycin, by Packaging USD Million (2018-2023)
  • Table 78. Middle East Natamycin, by Sources USD Million (2018-2023)
  • Table 79. Africa Natamycin, by Application USD Million (2018-2023)
  • Table 80. Africa Natamycin, by Packaging USD Million (2018-2023)
  • Table 81. Africa Natamycin, by Sources USD Million (2018-2023)
  • Table 82. North America Natamycin, by Country USD Million (2018-2023)
  • Table 83. North America Natamycin, by Application USD Million (2018-2023)
  • Table 84. North America Natamycin, by Packaging USD Million (2018-2023)
  • Table 85. North America Natamycin, by Sources USD Million (2018-2023)
  • Table 86. United States Natamycin, by Application USD Million (2018-2023)
  • Table 87. United States Natamycin, by Packaging USD Million (2018-2023)
  • Table 88. United States Natamycin, by Sources USD Million (2018-2023)
  • Table 89. Canada Natamycin, by Application USD Million (2018-2023)
  • Table 90. Canada Natamycin, by Packaging USD Million (2018-2023)
  • Table 91. Canada Natamycin, by Sources USD Million (2018-2023)
  • Table 92. Mexico Natamycin, by Application USD Million (2018-2023)
  • Table 93. Mexico Natamycin, by Packaging USD Million (2018-2023)
  • Table 94. Mexico Natamycin, by Sources USD Million (2018-2023)
  • Table 95. Natamycin Sales: by Application(K Tons)
  • Table 96. Natamycin Sales Dairy Products (Cheese, Sour Cream, Yoghurt) , by Region K Tons (2018-2023)
  • Table 97. Natamycin Sales Dried Meats , by Region K Tons (2018-2023)
  • Table 98. Natamycin Sales Juices , by Region K Tons (2018-2023)
  • Table 99. Natamycin Sales Pharmaceuticals , by Region K Tons (2018-2023)
  • Table 100. Natamycin Sales Others , by Region K Tons (2018-2023)
  • Table 101. Natamycin Sales: by Packaging(K Tons)
  • Table 102. Natamycin Sales Plastic Bottle , by Region K Tons (2018-2023)
  • Table 103. Natamycin Sales Glass Containers , by Region K Tons (2018-2023)
  • Table 104. Natamycin Sales Stainless Steel Containers , by Region K Tons (2018-2023)
  • Table 105. Natamycin Sales: by Sources(K Tons)
  • Table 106. Natamycin Sales Plants , by Region K Tons (2018-2023)
  • Table 107. Natamycin Sales Animals , by Region K Tons (2018-2023)
  • Table 108. Natamycin Sales Microorganisms , by Region K Tons (2018-2023)
  • Table 109. South America Natamycin Sales, by Country K Tons (2018-2023)
  • Table 110. South America Natamycin Sales, by Application K Tons (2018-2023)
  • Table 111. South America Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 112. South America Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 113. Brazil Natamycin Sales, by Application K Tons (2018-2023)
  • Table 114. Brazil Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 115. Brazil Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 116. Argentina Natamycin Sales, by Application K Tons (2018-2023)
  • Table 117. Argentina Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 118. Argentina Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 119. Rest of South America Natamycin Sales, by Application K Tons (2018-2023)
  • Table 120. Rest of South America Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 121. Rest of South America Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 122. Asia Pacific Natamycin Sales, by Country K Tons (2018-2023)
  • Table 123. Asia Pacific Natamycin Sales, by Application K Tons (2018-2023)
  • Table 124. Asia Pacific Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 125. Asia Pacific Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 126. China Natamycin Sales, by Application K Tons (2018-2023)
  • Table 127. China Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 128. China Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 129. Japan Natamycin Sales, by Application K Tons (2018-2023)
  • Table 130. Japan Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 131. Japan Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 132. India Natamycin Sales, by Application K Tons (2018-2023)
  • Table 133. India Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 134. India Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 135. South Korea Natamycin Sales, by Application K Tons (2018-2023)
  • Table 136. South Korea Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 137. South Korea Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 138. Australia Natamycin Sales, by Application K Tons (2018-2023)
  • Table 139. Australia Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 140. Australia Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 141. Rest of Asia-Pacific Natamycin Sales, by Application K Tons (2018-2023)
  • Table 142. Rest of Asia-Pacific Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 143. Rest of Asia-Pacific Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 144. Europe Natamycin Sales, by Country K Tons (2018-2023)
  • Table 145. Europe Natamycin Sales, by Application K Tons (2018-2023)
  • Table 146. Europe Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 147. Europe Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 148. Germany Natamycin Sales, by Application K Tons (2018-2023)
  • Table 149. Germany Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 150. Germany Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 151. France Natamycin Sales, by Application K Tons (2018-2023)
  • Table 152. France Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 153. France Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 154. Italy Natamycin Sales, by Application K Tons (2018-2023)
  • Table 155. Italy Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 156. Italy Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 157. United Kingdom Natamycin Sales, by Application K Tons (2018-2023)
  • Table 158. United Kingdom Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 159. United Kingdom Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 160. Netherlands Natamycin Sales, by Application K Tons (2018-2023)
  • Table 161. Netherlands Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 162. Netherlands Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 163. Rest of Europe Natamycin Sales, by Application K Tons (2018-2023)
  • Table 164. Rest of Europe Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 165. Rest of Europe Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 166. MEA Natamycin Sales, by Country K Tons (2018-2023)
  • Table 167. MEA Natamycin Sales, by Application K Tons (2018-2023)
  • Table 168. MEA Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 169. MEA Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 170. Middle East Natamycin Sales, by Application K Tons (2018-2023)
  • Table 171. Middle East Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 172. Middle East Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 173. Africa Natamycin Sales, by Application K Tons (2018-2023)
  • Table 174. Africa Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 175. Africa Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 176. North America Natamycin Sales, by Country K Tons (2018-2023)
  • Table 177. North America Natamycin Sales, by Application K Tons (2018-2023)
  • Table 178. North America Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 179. North America Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 180. United States Natamycin Sales, by Application K Tons (2018-2023)
  • Table 181. United States Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 182. United States Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 183. Canada Natamycin Sales, by Application K Tons (2018-2023)
  • Table 184. Canada Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 185. Canada Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 186. Mexico Natamycin Sales, by Application K Tons (2018-2023)
  • Table 187. Mexico Natamycin Sales, by Packaging K Tons (2018-2023)
  • Table 188. Mexico Natamycin Sales, by Sources K Tons (2018-2023)
  • Table 189. Company Basic Information, Sales Area and Its Competitors
  • Table 190. Company Basic Information, Sales Area and Its Competitors
  • Table 191. Company Basic Information, Sales Area and Its Competitors
  • Table 192. Company Basic Information, Sales Area and Its Competitors
  • Table 193. Company Basic Information, Sales Area and Its Competitors
  • Table 194. Company Basic Information, Sales Area and Its Competitors
  • Table 195. Company Basic Information, Sales Area and Its Competitors
  • Table 196. Company Basic Information, Sales Area and Its Competitors
  • Table 197. Company Basic Information, Sales Area and Its Competitors
  • Table 198. Company Basic Information, Sales Area and Its Competitors
  • Table 199. Natamycin: by Application(USD Million)
  • Table 200. Natamycin Dairy Products (Cheese, Sour Cream, Yoghurt) , by Region USD Million (2025-2030)
  • Table 201. Natamycin Dried Meats , by Region USD Million (2025-2030)
  • Table 202. Natamycin Juices , by Region USD Million (2025-2030)
  • Table 203. Natamycin Pharmaceuticals , by Region USD Million (2025-2030)
  • Table 204. Natamycin Others , by Region USD Million (2025-2030)
  • Table 205. Natamycin: by Packaging(USD Million)
  • Table 206. Natamycin Plastic Bottle , by Region USD Million (2025-2030)
  • Table 207. Natamycin Glass Containers , by Region USD Million (2025-2030)
  • Table 208. Natamycin Stainless Steel Containers , by Region USD Million (2025-2030)
  • Table 209. Natamycin: by Sources(USD Million)
  • Table 210. Natamycin Plants , by Region USD Million (2025-2030)
  • Table 211. Natamycin Animals , by Region USD Million (2025-2030)
  • Table 212. Natamycin Microorganisms , by Region USD Million (2025-2030)
  • Table 213. South America Natamycin, by Country USD Million (2025-2030)
  • Table 214. South America Natamycin, by Application USD Million (2025-2030)
  • Table 215. South America Natamycin, by Packaging USD Million (2025-2030)
  • Table 216. South America Natamycin, by Sources USD Million (2025-2030)
  • Table 217. Brazil Natamycin, by Application USD Million (2025-2030)
  • Table 218. Brazil Natamycin, by Packaging USD Million (2025-2030)
  • Table 219. Brazil Natamycin, by Sources USD Million (2025-2030)
  • Table 220. Argentina Natamycin, by Application USD Million (2025-2030)
  • Table 221. Argentina Natamycin, by Packaging USD Million (2025-2030)
  • Table 222. Argentina Natamycin, by Sources USD Million (2025-2030)
  • Table 223. Rest of South America Natamycin, by Application USD Million (2025-2030)
  • Table 224. Rest of South America Natamycin, by Packaging USD Million (2025-2030)
  • Table 225. Rest of South America Natamycin, by Sources USD Million (2025-2030)
  • Table 226. Asia Pacific Natamycin, by Country USD Million (2025-2030)
  • Table 227. Asia Pacific Natamycin, by Application USD Million (2025-2030)
  • Table 228. Asia Pacific Natamycin, by Packaging USD Million (2025-2030)
  • Table 229. Asia Pacific Natamycin, by Sources USD Million (2025-2030)
  • Table 230. China Natamycin, by Application USD Million (2025-2030)
  • Table 231. China Natamycin, by Packaging USD Million (2025-2030)
  • Table 232. China Natamycin, by Sources USD Million (2025-2030)
  • Table 233. Japan Natamycin, by Application USD Million (2025-2030)
  • Table 234. Japan Natamycin, by Packaging USD Million (2025-2030)
  • Table 235. Japan Natamycin, by Sources USD Million (2025-2030)
  • Table 236. India Natamycin, by Application USD Million (2025-2030)
  • Table 237. India Natamycin, by Packaging USD Million (2025-2030)
  • Table 238. India Natamycin, by Sources USD Million (2025-2030)
  • Table 239. South Korea Natamycin, by Application USD Million (2025-2030)
  • Table 240. South Korea Natamycin, by Packaging USD Million (2025-2030)
  • Table 241. South Korea Natamycin, by Sources USD Million (2025-2030)
  • Table 242. Australia Natamycin, by Application USD Million (2025-2030)
  • Table 243. Australia Natamycin, by Packaging USD Million (2025-2030)
  • Table 244. Australia Natamycin, by Sources USD Million (2025-2030)
  • Table 245. Rest of Asia-Pacific Natamycin, by Application USD Million (2025-2030)
  • Table 246. Rest of Asia-Pacific Natamycin, by Packaging USD Million (2025-2030)
  • Table 247. Rest of Asia-Pacific Natamycin, by Sources USD Million (2025-2030)
  • Table 248. Europe Natamycin, by Country USD Million (2025-2030)
  • Table 249. Europe Natamycin, by Application USD Million (2025-2030)
  • Table 250. Europe Natamycin, by Packaging USD Million (2025-2030)
  • Table 251. Europe Natamycin, by Sources USD Million (2025-2030)
  • Table 252. Germany Natamycin, by Application USD Million (2025-2030)
  • Table 253. Germany Natamycin, by Packaging USD Million (2025-2030)
  • Table 254. Germany Natamycin, by Sources USD Million (2025-2030)
  • Table 255. France Natamycin, by Application USD Million (2025-2030)
  • Table 256. France Natamycin, by Packaging USD Million (2025-2030)
  • Table 257. France Natamycin, by Sources USD Million (2025-2030)
  • Table 258. Italy Natamycin, by Application USD Million (2025-2030)
  • Table 259. Italy Natamycin, by Packaging USD Million (2025-2030)
  • Table 260. Italy Natamycin, by Sources USD Million (2025-2030)
  • Table 261. United Kingdom Natamycin, by Application USD Million (2025-2030)
  • Table 262. United Kingdom Natamycin, by Packaging USD Million (2025-2030)
  • Table 263. United Kingdom Natamycin, by Sources USD Million (2025-2030)
  • Table 264. Netherlands Natamycin, by Application USD Million (2025-2030)
  • Table 265. Netherlands Natamycin, by Packaging USD Million (2025-2030)
  • Table 266. Netherlands Natamycin, by Sources USD Million (2025-2030)
  • Table 267. Rest of Europe Natamycin, by Application USD Million (2025-2030)
  • Table 268. Rest of Europe Natamycin, by Packaging USD Million (2025-2030)
  • Table 269. Rest of Europe Natamycin, by Sources USD Million (2025-2030)
  • Table 270. MEA Natamycin, by Country USD Million (2025-2030)
  • Table 271. MEA Natamycin, by Application USD Million (2025-2030)
  • Table 272. MEA Natamycin, by Packaging USD Million (2025-2030)
  • Table 273. MEA Natamycin, by Sources USD Million (2025-2030)
  • Table 274. Middle East Natamycin, by Application USD Million (2025-2030)
  • Table 275. Middle East Natamycin, by Packaging USD Million (2025-2030)
  • Table 276. Middle East Natamycin, by Sources USD Million (2025-2030)
  • Table 277. Africa Natamycin, by Application USD Million (2025-2030)
  • Table 278. Africa Natamycin, by Packaging USD Million (2025-2030)
  • Table 279. Africa Natamycin, by Sources USD Million (2025-2030)
  • Table 280. North America Natamycin, by Country USD Million (2025-2030)
  • Table 281. North America Natamycin, by Application USD Million (2025-2030)
  • Table 282. North America Natamycin, by Packaging USD Million (2025-2030)
  • Table 283. North America Natamycin, by Sources USD Million (2025-2030)
  • Table 284. United States Natamycin, by Application USD Million (2025-2030)
  • Table 285. United States Natamycin, by Packaging USD Million (2025-2030)
  • Table 286. United States Natamycin, by Sources USD Million (2025-2030)
  • Table 287. Canada Natamycin, by Application USD Million (2025-2030)
  • Table 288. Canada Natamycin, by Packaging USD Million (2025-2030)
  • Table 289. Canada Natamycin, by Sources USD Million (2025-2030)
  • Table 290. Mexico Natamycin, by Application USD Million (2025-2030)
  • Table 291. Mexico Natamycin, by Packaging USD Million (2025-2030)
  • Table 292. Mexico Natamycin, by Sources USD Million (2025-2030)
  • Table 293. Natamycin Sales: by Application(K Tons)
  • Table 294. Natamycin Sales Dairy Products (Cheese, Sour Cream, Yoghurt) , by Region K Tons (2025-2030)
  • Table 295. Natamycin Sales Dried Meats , by Region K Tons (2025-2030)
  • Table 296. Natamycin Sales Juices , by Region K Tons (2025-2030)
  • Table 297. Natamycin Sales Pharmaceuticals , by Region K Tons (2025-2030)
  • Table 298. Natamycin Sales Others , by Region K Tons (2025-2030)
  • Table 299. Natamycin Sales: by Packaging(K Tons)
  • Table 300. Natamycin Sales Plastic Bottle , by Region K Tons (2025-2030)
  • Table 301. Natamycin Sales Glass Containers , by Region K Tons (2025-2030)
  • Table 302. Natamycin Sales Stainless Steel Containers , by Region K Tons (2025-2030)
  • Table 303. Natamycin Sales: by Sources(K Tons)
  • Table 304. Natamycin Sales Plants , by Region K Tons (2025-2030)
  • Table 305. Natamycin Sales Animals , by Region K Tons (2025-2030)
  • Table 306. Natamycin Sales Microorganisms , by Region K Tons (2025-2030)
  • Table 307. South America Natamycin Sales, by Country K Tons (2025-2030)
  • Table 308. South America Natamycin Sales, by Application K Tons (2025-2030)
  • Table 309. South America Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 310. South America Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 311. Brazil Natamycin Sales, by Application K Tons (2025-2030)
  • Table 312. Brazil Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 313. Brazil Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 314. Argentina Natamycin Sales, by Application K Tons (2025-2030)
  • Table 315. Argentina Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 316. Argentina Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 317. Rest of South America Natamycin Sales, by Application K Tons (2025-2030)
  • Table 318. Rest of South America Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 319. Rest of South America Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 320. Asia Pacific Natamycin Sales, by Country K Tons (2025-2030)
  • Table 321. Asia Pacific Natamycin Sales, by Application K Tons (2025-2030)
  • Table 322. Asia Pacific Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 323. Asia Pacific Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 324. China Natamycin Sales, by Application K Tons (2025-2030)
  • Table 325. China Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 326. China Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 327. Japan Natamycin Sales, by Application K Tons (2025-2030)
  • Table 328. Japan Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 329. Japan Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 330. India Natamycin Sales, by Application K Tons (2025-2030)
  • Table 331. India Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 332. India Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 333. South Korea Natamycin Sales, by Application K Tons (2025-2030)
  • Table 334. South Korea Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 335. South Korea Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 336. Australia Natamycin Sales, by Application K Tons (2025-2030)
  • Table 337. Australia Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 338. Australia Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 339. Rest of Asia-Pacific Natamycin Sales, by Application K Tons (2025-2030)
  • Table 340. Rest of Asia-Pacific Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 341. Rest of Asia-Pacific Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 342. Europe Natamycin Sales, by Country K Tons (2025-2030)
  • Table 343. Europe Natamycin Sales, by Application K Tons (2025-2030)
  • Table 344. Europe Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 345. Europe Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 346. Germany Natamycin Sales, by Application K Tons (2025-2030)
  • Table 347. Germany Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 348. Germany Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 349. France Natamycin Sales, by Application K Tons (2025-2030)
  • Table 350. France Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 351. France Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 352. Italy Natamycin Sales, by Application K Tons (2025-2030)
  • Table 353. Italy Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 354. Italy Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 355. United Kingdom Natamycin Sales, by Application K Tons (2025-2030)
  • Table 356. United Kingdom Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 357. United Kingdom Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 358. Netherlands Natamycin Sales, by Application K Tons (2025-2030)
  • Table 359. Netherlands Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 360. Netherlands Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 361. Rest of Europe Natamycin Sales, by Application K Tons (2025-2030)
  • Table 362. Rest of Europe Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 363. Rest of Europe Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 364. MEA Natamycin Sales, by Country K Tons (2025-2030)
  • Table 365. MEA Natamycin Sales, by Application K Tons (2025-2030)
  • Table 366. MEA Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 367. MEA Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 368. Middle East Natamycin Sales, by Application K Tons (2025-2030)
  • Table 369. Middle East Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 370. Middle East Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 371. Africa Natamycin Sales, by Application K Tons (2025-2030)
  • Table 372. Africa Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 373. Africa Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 374. North America Natamycin Sales, by Country K Tons (2025-2030)
  • Table 375. North America Natamycin Sales, by Application K Tons (2025-2030)
  • Table 376. North America Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 377. North America Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 378. United States Natamycin Sales, by Application K Tons (2025-2030)
  • Table 379. United States Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 380. United States Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 381. Canada Natamycin Sales, by Application K Tons (2025-2030)
  • Table 382. Canada Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 383. Canada Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 384. Mexico Natamycin Sales, by Application K Tons (2025-2030)
  • Table 385. Mexico Natamycin Sales, by Packaging K Tons (2025-2030)
  • Table 386. Mexico Natamycin Sales, by Sources K Tons (2025-2030)
  • Table 387. Research Programs/Design for This Report
  • Table 388. Key Data Information from Secondary Sources
  • Table 389. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Natamycin: by Application USD Million (2018-2023)
  • Figure 5. Global Natamycin: by Packaging USD Million (2018-2023)
  • Figure 6. Global Natamycin: by Sources USD Million (2018-2023)
  • Figure 7. South America Natamycin Share (%), by Country
  • Figure 8. Asia Pacific Natamycin Share (%), by Country
  • Figure 9. Europe Natamycin Share (%), by Country
  • Figure 10. MEA Natamycin Share (%), by Country
  • Figure 11. North America Natamycin Share (%), by Country
  • Figure 12. Global Natamycin: by Application K Tons (2018-2023)
  • Figure 13. Global Natamycin: by Packaging K Tons (2018-2023)
  • Figure 14. Global Natamycin: by Sources K Tons (2018-2023)
  • Figure 15. South America Natamycin Share (%), by Country
  • Figure 16. Asia Pacific Natamycin Share (%), by Country
  • Figure 17. Europe Natamycin Share (%), by Country
  • Figure 18. MEA Natamycin Share (%), by Country
  • Figure 19. North America Natamycin Share (%), by Country
  • Figure 20. Global Natamycin share by Players 2023 (%)
  • Figure 21. Global Natamycin share by Players (Top 3) 2023(%)
  • Figure 22. Global Natamycin share by Players (Top 5) 2023(%)
  • Figure 23. BCG Matrix for key Companies
  • Figure 24. Danisco (Denmark) Revenue, Net Income and Gross profit
  • Figure 25. Danisco (Denmark) Revenue: by Geography 2023
  • Figure 26. Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 27. Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 28. Lanzhou Weiri (China) Revenue, Net Income and Gross profit
  • Figure 29. Lanzhou Weiri (China) Revenue: by Geography 2023
  • Figure 30. Meihua Holdings Group Co., Ltd (China) Revenue, Net Income and Gross profit
  • Figure 31. Meihua Holdings Group Co., Ltd (China) Revenue: by Geography 2023
  • Figure 32. Chihon Biotechnology (China) Revenue, Net Income and Gross profit
  • Figure 33. Chihon Biotechnology (China) Revenue: by Geography 2023
  • Figure 34. VGP Pharmachem (Spain) Revenue, Net Income and Gross profit
  • Figure 35. VGP Pharmachem (Spain) Revenue: by Geography 2023
  • Figure 36. Beijing Oriental Rada Biotech Co., Ltd. (China) Revenue, Net Income and Gross profit
  • Figure 37. Beijing Oriental Rada Biotech Co., Ltd. (China) Revenue: by Geography 2023
  • Figure 38. Toku-E Company (United States) Revenue, Net Income and Gross profit
  • Figure 39. Toku-E Company (United States) Revenue: by Geography 2023
  • Figure 40. D & F Control Systems Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 41. D & F Control Systems Inc. (United States) Revenue: by Geography 2023
  • Figure 42. Avanscure Lifesciences Pvt. Ltd. (India) Revenue, Net Income and Gross profit
  • Figure 43. Avanscure Lifesciences Pvt. Ltd. (India) Revenue: by Geography 2023
  • Figure 44. Global Natamycin: by Application USD Million (2025-2030)
  • Figure 45. Global Natamycin: by Packaging USD Million (2025-2030)
  • Figure 46. Global Natamycin: by Sources USD Million (2025-2030)
  • Figure 47. South America Natamycin Share (%), by Country
  • Figure 48. Asia Pacific Natamycin Share (%), by Country
  • Figure 49. Europe Natamycin Share (%), by Country
  • Figure 50. MEA Natamycin Share (%), by Country
  • Figure 51. North America Natamycin Share (%), by Country
  • Figure 52. Global Natamycin: by Application K Tons (2025-2030)
  • Figure 53. Global Natamycin: by Packaging K Tons (2025-2030)
  • Figure 54. Global Natamycin: by Sources K Tons (2025-2030)
  • Figure 55. South America Natamycin Share (%), by Country
  • Figure 56. Asia Pacific Natamycin Share (%), by Country
  • Figure 57. Europe Natamycin Share (%), by Country
  • Figure 58. MEA Natamycin Share (%), by Country
  • Figure 59. North America Natamycin Share (%), by Country
List of companies from research coverage that are profiled in the study
  • Danisco (Denmark)
  • Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China)
  • Lanzhou Weiri (China)
  • Meihua Holdings Group Co., Ltd (China)
  • Chihon Biotechnology (China)
  • VGP Pharmachem (Spain)
  • Beijing Oriental Rada Biotech Co., Ltd. (China)
  • Toku-E Company (United States)
  • D & F Control Systems Inc. (United States)
  • Avanscure Lifesciences Pvt. Ltd. (India)
Select User Access Type

Key Highlights of Report


Apr 2024 176 Pages 82 Tables Base Year: 2023 Coverage: 15+ Companies; 18 Countries

Request Sample Pages

Budget constraints? Get in touch with us for special pricing


Check Discount Now
Global Natamycin Quantitative research analysis
Global Natamycin Qualitative Industry Analysis
DOWNLOAD SAMPLE PDF

Talk to Our Experts

Want to Customize Study?


"We employ Market statistics, Industry benchmarking, Patent analysis, and Technological Insights to derive requirements and provide customize scope of work."

Make an Enquiry Now

Frequently Asked Questions (FAQ):

The standard version of the report profiles players such as Danisco (Denmark), Zhejiang Silver-Elephant Bio-engineering Co., Ltd. (China), Lanzhou Weiri (China), Meihua Holdings Group Co., Ltd (China), Chihon Biotechnology (China), VGP Pharmachem (Spain), Beijing Oriental Rada Biotech Co., Ltd. (China), Toku-E Company (United States), D & F Control Systems Inc. (United States) and Avanscure Lifesciences Pvt. Ltd. (India) etc.
The Study can be customized subject to feasibility and data availability. Please connect with our sales representative for further information.
"Growing Use in Antifungal Pharmaceutical Products" is seen as one of major influencing trends for Natamycin Market during projected period 2023-2030.
The Natamycin market study includes a random mix of players, including both market leaders and some top growing emerging players. Connect with our sales executive to get a complete company list in our research coverage.

Know More About Global Natamycin Report?

Have a Query? Click Here

Other Related Reports

Alpha Olefin Comprehensive Study by Type (1-Butene, 1-Hexene, 1-Octene, Others), Application (Linear low-density polyethylene (LLDPE), High-density polyethylene (HDPE), Valeraldehyde, Plasticizers, L...
$ 3500
Ceramic Adhesives Comprehensive Study by Type (Epoxy Based, Acrylic Based, Superglue (Cyanoacrylate) Based), Application (Aerospace & Defense, Building & Construction, Automotive, Electrical & Electr...
$ 3650
Diesel Oxidation Catalyst Comprehensive Study by Type (Activated, Non-Activated), Application (Refinery Industry, Chemical Industry, Construction industry, Others) Players and Region - Global Market ...
$ 3500
Sodium Cyanide Comprehensive Study by Type (Solid Sodium Cyanide, Liquid Sodium Cyanide), Application (Mining Industry {Gold, Silver}, Chemical Industry, Pharmaceuticals Industry, Dye and Pigments In...
$ 3450
Synthetic Quartz Comprehensive Study by Type (Synthetic Quartz Crystal, Synthetic Quartz Glass, Others), Application (Electronics & Electrical, Automotive, Construction, Others), Color (Citrine (Yell...
$ 3450
Epoxy Composites Comprehensive Study by Type (Glass Fiber, Carbon Fiber, Others (Natural Fiber, Aramid Fiber)), Industry Verticals (Automotive & Transportation, Aerospace & Defense, Sporting Goods, E...
$ 3750